Small Cell Lung Cancer

Filter By:
01:00
D. Ross Camidge, MD, PhD, Director, Thoracic Oncology Clinical Program, University of Colorado Cancer Center, discusses a phase I study looking at AZD9291 in patients with non-small cell lung cancer. More on lung cancer: http://www.o...
by:onclivetv | 57 views
01:28
Alex Molasiotis, RN, PhD, professor, Head of School, School of Nursing, The Hong Kong Polytechnic University, discusses the results of a pilot feasibility study looking at inspiratory muscle training for the management of breathlessness in patients with lung cancer. More from this conference: htt...
by:onclivetv | 33 views
02:09
Abraham Chachoua, MD, The Jay and Isabel Fine Associate Professor of Oncology, NYU Langone Medical Center, associate director, Cancer Services, Perlmutter Cancer Center at NYU Langone, discusses ongoing clinical trials at NYU that are evaluating immunotherapy in patients with lung cancer.
by:onclivetv | 35 views
02:14
Fadlo R. Khuri, MD, FACP, professor, chair, hematology/medi​cal oncology, Emory University School of Medicine, deputy director, Winship Cancer Institute, discusses survivorship in lung cancer.
by:onclivetv | 28 views
01:17
Scott Santarella, president, CEO, Bonnie J. Addario Lung Cancer Foundation, discusses some exciting updates in the field of lung cancer.
by:onclivetv | 44 views
07:22
The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases. GRACEcast 246 Lung
by:cancergrace | 130 views
07:18
Lung cancer patients with high MET amplification appear to do well on Xalcori (crizotinib), a drug that is approved for ALK positive patients. GRACEcast 242 Lung
by:cancergrace | 198 views
04:10
http://cance... Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side effect concerns some. GRACEcast 240 Lung
by:cancergrace | 158 views
11:36
http://cance... EGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial. GRACEcast 237 Lung
by:cancergrace | 153 views
08:16
http://cance... An analysis of two large studies of EGFR lung cancer patients tried to determine if Gilotrif helped patients live longer. GRACEcast 236 Lung
by:cancergrace | 207 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)